Autophagy is closely associated with cerebral ischaemia/
reperfusion injury, but the underlying mechanisms are unknown. We investigated whether
Spautin-1 ameliorates cerebral ischaemia/
reperfusion injury by inhibiting autophagy and whether its derived pyroptosis is involved in this process. We explored the mechanism of
Spautin-1 in cerebral ischaemia/reperfusion. To answer these questions, healthy male Sprague-Dawley rats were exposed to
middle cerebral artery occlusion for 60 minutes followed by reperfusion for 24 hours. We found that cerebral ischaemia/reperfusion increased the expression levels of autophagy and pyroptosis-related
proteins. Treatment with
Spautin-1 reduced the
infarct size and water content and restored some neurological functions. In vitro experiments were performed using
oxygen-
glucose deprivation/reoxygenation to model PC12 cells. The results showed that PC12 cells showed a significant decrease in cell viability and a significant increase in ROS and autophagy levels.
Spautin-1 treatment reduced autophagy and ROS accumulation and attenuated NLRP3
inflammasome-dependent pyroptosis. However, these beneficial effects were greatly blocked by USP13 overexpression, which significantly counteracted the inhibition of autophagy and NLRP3
inflammasome-dependent ferroptosis by
Spautin-1. Together, these results suggest that
Spautin-1 may ameliorate cerebral ischaemia-
reperfusion injury via the autophagy/pyroptosis pathway. Thus, inhibition of autophagy may be considered as a promising therapeutic approach for cerebral ischaemia-
reperfusion injury.